15h30 16h00. 16h00 17h30. 17h40 19h Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e

Size: px
Start display at page:

Download "15h30 16h00. 16h00 17h30. 17h40 19h Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e"

Transcription

1 CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding (Julia Turner) - Previously on PrEP, now pregnant. What to do? (Tshidi Sebitloane) - Teen adherence (Juliet Houghton) - Breast abnormalities in adolescents receiving ART (Jackie Dunlop) Moherndran Archary 15h30 16h00 16h00 17h30 17h40 19h00 Session 1B Adult cases (Michelle Venter, Kim Roberg) - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion (Gary Maartens, Yunus Moosa) Jeremy Nel Session 2: Open Session Debate: Undetectable = Untransmittable - Yes (Annemarie Wensing) - No (Graeme Meintjes) Yunus Moosa Session 3: Opening Plenary Official conference opening Mechanism of resistance (Douglas Richman) HIV drug resistance: are we about to win the war? (John Mellors) Annemarie Wensing Session 1C - Skills building - Nurse cases - Cases primary healthcare, rural doctors (Ndiviwe Mphothulo, Jenny Nash) - Cases nurses (Talitha Crowley, Gloria Mthombeni) - Panel discussion: Integration; Restarting (Ndiviwe Mphothulo, Talitha Crowley, Gloria Mthombeni, Jenny Nash Gloria Maimela Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e

2 19h00 21h00 Opening Cocktail Function THURSDAY, 25 OCTOBER h30 08h15 Session 4A Stock outs and medicine availability - Stop Stockouts Project - Essential medicines to add to the formulary (Amir Shroufi) - Not deaf or dead! The seven-year journey of bedaquiline as a third choice for all South Africans with MDR-TB, as told by one fortunate MDR-TB survivor. (Arne von Delft) 08h20 10h15 10h15 10h30 10h30 12h00 Session 5: Plenary Session How are we doing with HIV self-screening? (Francois Venter) - How are we doing with Universal test and treat? - How are we doing with viral suppression? (Sergio Carmona) Session 6A Session 6B Pharmacovigilance and registers - Pharmacovigilance (Karen Cohen) - Pregnancy register - Registers and centralised reporting Gary Maartens - Skills building session Infant testing - Swallowing tablets (Leon Levin) - Optimising formulations (Carol Ruffell) - The latest on infant testing, and how to access (Gayle Sherman) - Switching in children (Helena Rabie) Session 4B Ethics and research - The informed consent process (Lucy Allais and Mary Carman) Session 6C Ethics and the Law - Whistle-blowing in the health-sector - Mandatory testing (Wayne Ncube) - Ethics on how health budgets are split (Marije Versteeg-Mojanaga) - Q&A Lucy Allais Southern African HIV Clinicians Society Conference 2018 programme subject to change 3 P a g e

3 12h00 13h30 Lunch, exhibition and posters - Weight and age (Helena Rabie) James Nuttall Satellite Session 7 GlaxoSmithKline session 13h30 15h00 15h00 15h30 15h30 17h00 Session 8A Cancer treatment models - Kaposi Sarcoma (Zainab Mohamed) - Lymphoma - Priorities for cervical cancer prevention among HIV-infected women (Masangu Mulongo) - Update on cancer treatment (Adam Nosworthy) Moosa Patel Hall 5 Session 9A An update on - Integrase inhibitors (Francois Venter) - Protease Inhibitors (Sipho Dlamini) - NRTIs (Yunus Moosa) - NNRTIs (Michelle Moorhouse) Session 8B Resistance - Viral resistance first-line and second-line (Graeme Meintjes) - At which detectable viral load should we switch? (Lucas Hermans) - Third-line treatment. Feedback on outcome of patients on national third-line regimen (Michelle Moorhouse) - Transmitted drug resistance: surveillance, implications, future (Cloete van Vuuren) Theresa Rossouw Session 9B What s coming / What s missing in paediatrics - Integrase inhibitors (James Nuttall) - Protease Inhibitors (Leon Levin) Session 8C Prevention - Non-biomedical approaches (Sue Goldstein) - Condoms (Mags Beksinska) - Update on trials of vaccines and monoclonals in SA; how PrEP could augment these approaches (Fatima Laher) - Voluntary medical male circumcision (Limakatso Lebina) - Treatment as prevention (Francois Venter) Fatima Laher Session 9C Modelling and scale-up - What are the numbers telling us - How the epidemic informs resource planning Cost effectiveness of TLD versus TEE (Gesine Meyer-Rath) Southern African HIV Clinicians Society Conference 2018 programme subject to change 4 P a g e

4 17h10 18h40 18h50 20h20 - Drug-drug interaction (Gary Maartens) Karen Cohen Session 10A Skills building session Resistance - Third-line (Leon Levin) - Paediatric third-line (Moherndran Archary) - Stanford database - how to interpret resistance test results (Robert Shafer) Cloete van Vuuren - Drug interactions (Mohendren Archary) Nosisa Sipambo Session 10B Skills building session Counselling - How to deliver HIV risk reduction counselling in 2018 (Janan Dietrich) - Integrating HIV prevention with other services (Natasha Davies) - How to tell a teenager they have HIV: A practical approach (Julia Turner and Leon Levin) Pierre Brouard Session 11: Debate (Open Session) Hall 4 Implications of scarcer resources for 90:90:90 (Gloria Maimela) - Panel: Elliot Raizes, Annemarie Wensing, Jean Nachega, Francois Venter FRIDAY, 26 OCTOBER h30 08h15 Southern African HIV Clinicians Society AGM Session 10C - Skills building session - Basic science (Carole Wallis, Gillian Hunt, Tendesayi Kufa-Chakezha) Gillian Hunt 08h30 10h00 Session 12: Plenary Our current understanding of antibodies (Nono Mhkize) Why do we need cure (John Mellors) How do you measure cure (Monique Nijhuis) Management of patients with advanced HIV (Graeme Meintjes) Moeketsi Mathe Southern African HIV Clinicians Society Conference 2018 programme subject to change 5 P a g e

5 10h00 10h30 10h30 12h00 12h00 13h30 Session 13A Opportunistic infections - An approach to intracranial mass lesions in HIV patients (Dave Stead) - Pneumocystis pneumonia (Michelle Wong) - Endemic mycoses in HIV patients (Jade Mogambery) - An approach to chronic diarrhoea (Sipho Dlamini) Colin Menezes Lunch, exhibition and posters Session 13B HIV and TB in children and adults - Paediatric TB diagnosis and management (Ashendri Pillay) - TB in children and HIV-TB coinfection (Fiona Kritzinger) - TB in adults and HIV-TB coinfection (Ndiviwe Mphothulo) - TB and HIV co-infection including IRIS Session 13C Key populations and mobile populations - Injecting drug users in the region (Andrew Scheibe) - Sex workers including satellite clinics; peer support (Naomi Hill) - Engaging in care (Naomi Hill) - Testing in taxi ranks (Thandeka Khoza) Kholi Buthelezi Satellite Session 14 GILEAD session 13h30 15h00 15h00 15h30 15h30 17h00 Session 15: Plenary Botswana Dolutegravir experience (Ava Avalos) Could good point-of-care testing revolutionise issues in the region? (Peter Manyike) Balancing politicians, ministries of health, communities and donors Session 16A Session 16B Skills building Clinical skills building Should the private sector be treating TB? Yes Session 16C Update on PMTCT Southern African HIV Clinicians Society Conference 2018 programme subject to change 6 P a g e

6 17h10 18h40 (Henry Sunpath, Yunus Moosa) Session 17A Hall 4 DTG in pregnancy and breastfeeding No Kogie Naidoo - Where are we with PMTCT, including epidemiology (Landon Myer) - Transmission of HIV in breastfeeding (Ameena Goga) - Pregnant women on ART programmatic issues (Coceka Mnyani) - Contraception, clinical issues, MPTs and new technologies (Helen Rees) Tshidi Sebitloane 19h00 22h30 Celebratory Dinner (RSVP only additional fee applies) SATURDAY, 27 OCTOBER h30 08h15 Session 18A Meet the Professor / Clinician How did I start my academic / research career? (Dave Spencer; Francois Venter; Michelle Moorhouse; Yunus Moosa; Gary Maartens) Moeketsi Mathe 08h30 10h00 Session 19: Plenary Vaccinations - Overview (Benjamin Kagina) - Influenza vaccines (Shabir Madhi) - HIV vaccines - SAHCS vaccination guidelines (Sipho Dlamini) Rudzani Muloiwa Session 18B Adolescent health c/o Wits RHI Southern African HIV Clinicians Society Conference 2018 programme subject to change 7 P a g e

7 10h00 10h30 10h30 12h00 12h00 13h30 Session 20A Noncommunicable diseases - Inflammation (Dave Spencer) - Hypertension - Obesity (Denasha Reddy) - Mental health (John Joska) - Injection drug use, HIV and hepatitis (Moeketsi Mathe) Marlin McKay Lunch, exhibition and posters Session 20B Ethics and technology - Electronic medical records (Sandile Mhlongo) - Digital database and the PoPI act (Siraaj Adams) - Ethico-legal framework for biobank research in SA (Safia Mahomed) Funeka Bango Session 20C Sexually transmitted infections - Strategies to achieve STI control in South Africa (Remco Peters) - Hepatitis C (Andrew Scheibe) - Update on vaginal microbiome and HIV - In context of PrEP (Danielle Travill) - Management of STIs in HIV+ population case-based (Ranmini Kuluratne) Helen Rees Satellite Session 21 Johnson & Johnson session 13h30 15h00 15h10 16h40 Session 22A - Advanced HIV Management - Care of aging patients (Marlin McKay) - Cryptococcal meningitis (Charlotte Sriruttan) - Palliative care (Dave Spencer) Dave Spencer Session 23A Skills building Session 22B Treatment optimisation - (Polly Clayden, Francois Venter, Gary Maartens, Michelle Moorhouse, Graeme Meintjes, Landon Myer) Polly Clayden Session 23B Adherence - Adherence (Catherine Orrell) Session 22C Best abstracts session Moeketsi Mathe Session 23C - Quality Improvement c/o the Aurum Institute Southern African HIV Clinicians Society Conference 2018 programme subject to change 8 P a g e

8 16h50 18h15 18h15 18h20 Guidelines: all new (Sipho Dlamini, James Nuttall, Dave Spencer, Natasha Davies, Michelle Moorhouse) Moeketsi Mathe - Adherence clubs (MSF) - Role of viral load testing in adherence (Henry Sunpath) Maria Sibanyoni Session 24: Closing Plenary Big challenges in public health Big challenges in TB preventative therapy Big challenges in introducing and scaling up new prevention technologies (Helen Rees) Gary Maartens Conference closing Moeketsi Mathe Southern African HIV Clinicians Society Conference 2018 programme subject to change 9 P a g e

Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e

Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now

More information

Session 1B - Auditorium Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion

Session 1B - Auditorium Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now

More information

Session 1B. - Hall 4. 15h30 16h00 Refreshments, exhibition and posters - Hall 5 16h00 17h30 Session 2: Open Session. - Hall 4

Session 1B. - Hall 4. 15h30 16h00 Refreshments, exhibition and posters - Hall 5 16h00 17h30 Session 2: Open Session. - Hall 4 CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding (Julia Turner) - Previously

More information

versus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects

versus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects PRE-CONFERENCE WORKSHOPS WEDNESDAY, 24 OCTOBER 2018 10h00 14h00 Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop ITREMA trial feedback PrEP for the private

More information

Session 1B. - Hall 4. - Hall 4

Session 1B. - Hall 4. - Hall 4 CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding (Julia Turner) - Previously

More information

SA HIV Clinicians Society Conference Excelling in Clinical Care : Programme

SA HIV Clinicians Society Conference Excelling in Clinical Care : Programme WEDNESDAY, 24 SEPTEMBER 2014 SA HIV Clinicians Society Conference 2014 - Excelling in Clinical Care : Programme 12h00-19h00 REGISTRATION 10h00-14h00 PRE-CONFERENCE WORKSHOP Metropolitan Health sponsored

More information

SA HIV Clinicians Society Conference Excelling in Clinical Care : Programme

SA HIV Clinicians Society Conference Excelling in Clinical Care : Programme WEDNESDAY, 24 SEPTEMBER 2014 SA HIV Clinicians Society Conference 2014 - Excelling in Clinical Care : Programme 12h00-19h00 REGISTRATION 10h00-14h00 PRE-CONFERENCE WORKSHOP Metropolitan Health sponsored

More information

SA HIV Clinicians Society Conference Excelling in Clinical Care : Programme

SA HIV Clinicians Society Conference Excelling in Clinical Care : Programme SA HIV Clinicians Society Conference 2014 - Excelling in Clinical Care : Programme WEDNESDAY, 24 SEPTEMBER 2014 08h00-19h00 10h00-13h55 12h30 13h55 REGISTRATION PRE-CONFERENCE WORKSHOP Metropolitan Health

More information

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84 Clinical guidelines across THE CONTINuUM OF CARE: LINKING PEOPLE DIAGNOSEd WiTH hiv infection to hiv care and treatment 06 6.1 Introduction 84 6.2 Good practices for linkage to care 84 6.3 General care

More information

World Health Organization. A Sustainable Health Sector

World Health Organization. A Sustainable Health Sector World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL

More information

Immunisation in people living with HIV. Dr Bernadett Gosnell, Department of Infectious Diseases, UKZN

Immunisation in people living with HIV. Dr Bernadett Gosnell, Department of Infectious Diseases, UKZN Immunisation in people living with HIV Dr Bernadett Gosnell, Department of Infectious Diseases, UKZN Calculating immunisation s return on investment In Gavi-supported countries, 2011 2020 48x (full income

More information

How are we doing with Universal Test and Treat?

How are we doing with Universal Test and Treat? How are we doing with Universal Test and Treat? Francois Venter October 2018 Thanks DoH, WHO, PEPFAR, CHAI, UCT, Joep Lange Institute, Celicia Serenata, Steve Smith, David Allen Optimising ART Consortia

More information

TasP and PrEP- Wishful thinking in the developing world?

TasP and PrEP- Wishful thinking in the developing world? TasP and PrEP- Wishful thinking in the developing world? Professor Helen Rees Executive Director, WRHI, Wits Reproductive Health and HIV Institute & Ad Hominem Professor, Department of Ob/Gyn, University

More information

Updates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013

Updates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013 Updates on Revised Antiretroviral Treatment Guidelines 2013 Overview 27 March 2013 Introduction of Fixed Dose combination (FDC) FDCs will be available in facilities on 1 April 2013 The FDC ARV that will

More information

PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE

PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE CHAPTER 2 PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE 2.1 INTRODUCTION Achieving quality integrated HIV services at your health centre is dependant on good planning and management. This chapter

More information

7 th FIDSSA CONFERENCE 2017 Programme as at 11 May 2017 PROVISIONAL ACADEMIC PROGRAMME

7 th FIDSSA CONFERENCE 2017 Programme as at 11 May 2017 PROVISIONAL ACADEMIC PROGRAMME THURSDAY 9 NOVEMBER 15h00 17h00 Conference Registration FIDSSA Official Opening Ceremony 17h00 17h15 Welcome & Opening - Marc Mendelson (FIDSSA President) PLENARY SESSION 1: Emerging and Re-Emerging Infectious

More information

Future trends of drug resistance and prospects of antiviral therapy. Doug Richman International Drug Resistance Workshop Johannesburg 24 October 2018

Future trends of drug resistance and prospects of antiviral therapy. Doug Richman International Drug Resistance Workshop Johannesburg 24 October 2018 Future trends of drug resistance and prospects of antiviral therapy Doug Richman International Drug Resistance Workshop Johannesburg 24 October 2018 The principles of HIV drug resistance are well established

More information

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness

More information

Impact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines

Impact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines Impact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines Thu-Ha Dinh, MD., MS., US CDC/GAP Ameena Goga, MD., MS., MRC/HSRU,

More information

ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS

ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS Dr T Chidarikire HIV PREVENTION STRATEGIES 13 JUNE 2017 1 Purpose To share the Health Sector HIV Prevention Strategy with

More information

2nd line failure, provincial evaluation process for 3rd line therapy, 3rd line treatment options James Nuttall

2nd line failure, provincial evaluation process for 3rd line therapy, 3rd line treatment options James Nuttall 2nd line failure, provincial evaluation process for 3rd line therapy, 3rd line treatment options James Nuttall Paediatric Infectious Diseases Unit, Red Cross War Memorial Children s Hospital & University

More information

ITREMA is a collaborative project between several universities in The Netherlands and South Africa and Ndlovu Care Group.

ITREMA is a collaborative project between several universities in The Netherlands and South Africa and Ndlovu Care Group. ITREMA is a collaborative project between several universities in The Netherlands and South Africa and Ndlovu Care Group. Objective: To do research into the best way to use viral load testing to ensure

More information

IFMSA Policy Statement Ending AIDS by 2030

IFMSA Policy Statement Ending AIDS by 2030 IFMSA Policy Statement Ending AIDS by 2030 Proposed by IFMSA Team of Officials Puebla, Mexico, August 2016 Summary IFMSA currently acknowledges the HIV epidemic as a major threat, which needs to be tackled

More information

Objectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)

Objectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT) Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission

More information

Overview of Safer Conception Services at Wits RHI

Overview of Safer Conception Services at Wits RHI SA AIDS Satellite Session 13 June 2017 Presented by Diantha Pillay on behalf of Dr. Natasha Davies, Sheree Swartz, Nicolette Naidoo & Saiqa Mullick Overview of Safer Conception Services at Wits RHI Safer

More information

Management of HIV Infected Children and Adolescents: Public Sector Approach in Kenya

Management of HIV Infected Children and Adolescents: Public Sector Approach in Kenya Management of HIV Infected Children and Adolescents: Public Sector Approach in Kenya KPA 2018 24-04-2018 Dr. Margaret Wainaina- Wafula Outline Introduction Evaluation of a child living with HIV. Standard

More information

Catherine Martin. Abstract #157. SA AIDS Conference. June 2017

Catherine Martin. Abstract #157. SA AIDS Conference. June 2017 Catherine Martin SA AIDS Conference Integrated sexual and reproductive health services as an entry point to HIV testing, prevention and care for adolescent girls and young women in Johannesburg, South

More information

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018 South Africa s National HIV Programme Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH 23 October 2018 Overview The HIV and AIDS sub-programme at NDOH is responsible for: policy formulation, coordination,

More information

Multiple choice questions: ANSWERS

Multiple choice questions: ANSWERS Multiple choice questions: ANSWERS Chapter 1. Diagnosis and promotion of serostatus awareness in sub-saharan Africa 1. Antiretroviral therapy reduces HIV transmission from a HIV- positive person to a susceptible

More information

Strengthening the Evidence for HIV Investments: Allocative Efficiency of HIV Responses: Results and Experiences

Strengthening the Evidence for HIV Investments: Allocative Efficiency of HIV Responses: Results and Experiences Strengthening the Evidence for HIV Investments: Allocative Efficiency of HIV Responses: Results and Experiences Presentation by: Dr Maxim Berdnikov, Global Fund Importance of Evidence of Impact under the

More information

PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV

PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV Madhuri Lad, DO, FACOI, AAHIVS Clinical Assistant Professor OSU Department of Internal Medicine OBJECTIVES Demographics Definitions Diagnosis

More information

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS Investing for Impact Prioritizing HIV Programs for GF Concept Notes Lisa Nelson, WHO Iris Semini, UNAIDS Top 5 Lessons Learned 1 2 3 4 5 Prioritize within the allocation amount Separate above allocation

More information

EACS HIV Summer School PRELIMINARY PROGRAMME

EACS HIV Summer School PRELIMINARY PROGRAMME EACS HIV Summer School Thursday, August 30, 2018 Monday, September 3, 2018 Montpellier, France This 5-day residential course is designed for clinicians experienced in HIV management who want an update

More information

Prioritized research questions for adolescent HIV testing, treatment and service delivery

Prioritized research questions for adolescent HIV testing, treatment and service delivery Prioritized research questions for adolescent HIV testing, treatment and service delivery The World Health Organization (WHO) and the Collaborative Initiative for Paediatric HIV Education and Research

More information

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES JULY 2014 Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for

More information

Impact of ART resistance in sub Saharan Africa

Impact of ART resistance in sub Saharan Africa Impact of ART resistance in sub Saharan Africa Elliot Raizes, MD Division of Global HIV/TB US Centers for Disease Control and Prevention ITREMA Resistance Training Workshop 24 October, 2018 Center for

More information

Program to control HIV/AIDS

Program to control HIV/AIDS 90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,

More information

GLOBAL AIDS MONITORING REPORT

GLOBAL AIDS MONITORING REPORT KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017

More information

WHO WHO AIDS 2018 JOIN US AT

WHO WHO AIDS 2018 JOIN US AT WHO AIDS 2018 JOIN US AT WHO at AIDS 2018 TEDROS GHEBREYESUS Director-General, WHO ZSUZSANNA JAKAB WHO Regional Director for Europe REN MINGHUI WHO Assistant Director-General for Communicable Diseases

More information

Differentiated Care Improving Engagement and Retention in HIV Care. Meg Doherty, MD PhD MPH World Health Organization

Differentiated Care Improving Engagement and Retention in HIV Care. Meg Doherty, MD PhD MPH World Health Organization Differentiated Care Improving Engagement and Retention in HIV Care Meg Doherty, MD PhD MPH World Health Organization Why differentiated care and how can it facilitate epidemic control Effects on linkage,

More information

THE ROLE OF THE SOUTH AFRICAN SOCIETY OF PHYSIOTHERAPY IN SUPPORT OF THE NATIONAL HIV & AIDS AND STI STRATEGIC PLAN FOR SOUTH AFRICA

THE ROLE OF THE SOUTH AFRICAN SOCIETY OF PHYSIOTHERAPY IN SUPPORT OF THE NATIONAL HIV & AIDS AND STI STRATEGIC PLAN FOR SOUTH AFRICA THE ROLE OF THE SOUTH AFRICAN SOCIETY OF PHYSIOTHERAPY IN SUPPORT OF THE NATIONAL HIV & AIDS AND STI STRATEGIC PLAN FOR SOUTH AFRICA 2012-2016 South African Society of Physiotherapy P.O. Box 752378 Gardenview

More information

Efavirenz vs dolutegravir for 1st line ART: Is it time to change? The argument AGAINST. Graeme Meintjes University of Cape Town

Efavirenz vs dolutegravir for 1st line ART: Is it time to change? The argument AGAINST. Graeme Meintjes University of Cape Town Efavirenz vs dolutegravir for 1st line ART: Is it time to change? The argument AGAINST Graeme Meintjes University of Cape Town Benefits of dolutegravir Superior efficacy in SINGLE trial Side effect profile

More information

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a

More information

Biomedical Prevention Update Thomas C. Quinn, M.D.

Biomedical Prevention Update Thomas C. Quinn, M.D. Biomedical Prevention Update Thomas C. Quinn, M.D. Associate Director of International Research National Institute of Allergy and Infectious Diseases Director, Johns Hopkins Center for Global Health Global

More information

Evolving HIV Treatment Paradigms What we need to know

Evolving HIV Treatment Paradigms What we need to know Evolving HIV Treatment Paradigms What we need to know Benjamin Young International Association of Providers of AIDS Care Washington, DC, USA Evolving HIV Treatment Paradigms When/who to treat Better medicines

More information

PEPFAR Priorities & HIV Drug Resistance: Where are we heading and what has us worried

PEPFAR Priorities & HIV Drug Resistance: Where are we heading and what has us worried PEPFAR Priorities & HIV Drug Resistance: Where are we heading and what has us worried Elliot Raizes, MD Division of Global HIV & TB CDC Center for Global Health May 3, 2016 Center for Global Health Division

More information

The CQUIN Learning Network. Adolescents Living with HIV: Legal framework for testing, treatment, and transition, Challenges and Priorities: Uganda

The CQUIN Learning Network. Adolescents Living with HIV: Legal framework for testing, treatment, and transition, Challenges and Priorities: Uganda The CQUIN Learning Network Adolescents Living with HIV: Legal framework for testing, treatment, and transition, Challenges and Priorities: Uganda Teddy N. Chimulwa STD/AIDS Control Program, Ministry of

More information

Objectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care.

Objectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care. 1:30 2:30pm HIV Update SPEAKER Gordon Dickinson, MD Presenter Disclosure Information The following relationships exist related to this presentation: Gordon Dickinson, MD, has no financial relationships

More information

ART for prevention the task ahead

ART for prevention the task ahead ART for prevention the task ahead Dr Teguest Guerma WHO/HQS WHO's role and vision Status of the epidemic Overview Progress and challenges in treatment and prevention scale up ART for prevention Questions

More information

BUDGET AND RESOURCE ALLOCATION MATRIX

BUDGET AND RESOURCE ALLOCATION MATRIX Strategic Direction/Function ILO Strengthened capacity of young people, youth-led organizations, key service providers and partners to develop, implement, monitor and evaluate HIV prevention programmes

More information

TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES

TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES POLICY BRIEF HIV TREATMENT TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES JULY 2017 WHO This policy brief provides advice on a phased approach to transitioning to new WHO-recommended HIV treatment

More information

Programme. Co-Chairs. Take the conversation further online follow AIDS #AIDS2016

Programme. Co-Chairs. Take the conversation further online follow AIDS #AIDS2016 EVIDENCE TOACTION This session will highlight the essential role that collaborative research plays in improving public sector policies and services for HIV treatment and prevention. Across southern Africa

More information

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State

More information

Towards universal access

Towards universal access Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress

More information

ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF

ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF PrEP MTN Regional Meeting Cape Town 20 September 2017 Dhevium Govender South African Medical Research Council HIV Prevention Research Unit Quality/Regulatory

More information

INTRODUCTION AND GUIDING PRINCIPLES

INTRODUCTION AND GUIDING PRINCIPLES CHAPTER 1 INTRODUCTION AND GUIDING PRINCIPLES The Operations Manual is intended for use in countries with high HIV prevalence and provides operational guidance on delivering HIV services at health centres.

More information

Diagnosing HIV/AIDS. Marissa Humphrey MSIV New York Medical College GE/NMF Scholar

Diagnosing HIV/AIDS. Marissa Humphrey MSIV New York Medical College GE/NMF Scholar Diagnosing HIV/AIDS Marissa Humphrey MSIV New York Medical College GE/NMF Scholar Introduction The World Health Organization estimates that 7 percent of all AIDS cases have occurred in Africa and the highest

More information

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical

More information

Strategies to achieve STI control in South Africa Prof Remco Peters

Strategies to achieve STI control in South Africa Prof Remco Peters Strategies to achieve STI control in South Africa Prof Remco Peters 4 th South African HIV Clinicians Society Conference 27th of October 2018 The spectrum of STIs This presentation has been slightly amended

More information

Can we make first line ART better?

Can we make first line ART better? Can we make first line ART better? Dr Angela Hartwig 8 th SA AIDS Conference, Durban Skills Building Session 15 June 2017 With thanks to Francois Venter and the people who gave him slides Characteristics

More information

INTERNAL QUESTIONS AND ANSWERS DRAFT

INTERNAL QUESTIONS AND ANSWERS DRAFT WHO CONSOLIDATED GUIDELINES ON THE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION Background: INTERNAL QUESTIONS AND ANSWERS DRAFT At the end of 2012, 9.7 million people were receiving

More information

Day Seven: Helping HIV Affected Children and Orphans

Day Seven: Helping HIV Affected Children and Orphans Note: This training material is continually being evaluated and updated to reflect current needs and best practices therefore it should be viewed as work in progress. Any person, organization, or institution

More information

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms) IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,

More information

Genotypic Resistance Testing in Routine Care in South Africa:

Genotypic Resistance Testing in Routine Care in South Africa: Genotypic Resistance Testing in Routine Care in South Africa: Is the Juice Worth the Squeeze? Mark Siedner Africa Health Research Institute Harvard Medical School Conflicts of Interest^* No financial conflicts

More information

Blanche Heriot Unit Patient Information and Discussion Event Wednesday 9th August pm Room 3 Chertsey House St Peter s Hospital

Blanche Heriot Unit Patient Information and Discussion Event Wednesday 9th August pm Room 3 Chertsey House St Peter s Hospital Blanche Heriot Unit Patient Information and Discussion Event Wednesday 9th August 6.30-8.00pm Room 3 Chertsey House St Peter s Hospital www.england.nhs.uk Agenda Heath Watch Surrey County Council and NHS

More information

WHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team

WHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team WHO HIV Drug Resistance Prevention and Assessment Strategy Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team Eastern & Southern African Countries (ESA) 2 The HIV epidemic

More information

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a

More information

CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016

CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016 CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016 MORNING PLENARY LECTURES: LIBERTY BALLROOM (M4) 9:00 9:15 AM Welcome and Introductions Conference Co-Chairs: Laura W. Cheever, MD, ScM; Michael S.

More information

HIV Prevention in Clinical Care Settings

HIV Prevention in Clinical Care Settings NORTHWEST AIDS EDUCATION AND TRAINING CENTER HIV Prevention in Clinical Care Settings Jeanne Marrazzo, MD, MPH Professor, Division of Allergy and Infectious Diseases University of Washington HIV Prevention

More information

Sexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012

Sexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012 Sexual and Reproductive Health and HIV Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012 Global estimates of HIV-(2009) People living with HIV 33.3 million [31.4 35.3

More information

Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know

Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know Carolyn K. Burr, EdD, RN Co-Clinical Director Deputy Director François-Xavier Bagnoud Center December 17 th, 2013

More information

Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions

Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions Harvard-Brazil Collaborative Public Health Field Course January 2014 Lecture # 8 Building specialized knowledge: HIV Aluisio Segurado Department of Infectious Diseases School of Medicine, University of

More information

Overview of Paediatric HIV Treatment and Prevention: From Then to Now. Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda

Overview of Paediatric HIV Treatment and Prevention: From Then to Now. Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda Overview of Paediatric HIV Treatment and Prevention: From Then to Now Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda Outline The plight of HIV infected children (1980s and 1990s) Trends

More information

Modelling the impact of HIVDR : the cost of inaction

Modelling the impact of HIVDR : the cost of inaction WHO Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan Webinars 12 13 Dec 2016 Modelling the impact of HIVDR : the cost of inaction Andrew

More information

HIV Epidemic in India

HIV Epidemic in India HIV Epidemic in India Dr.R.R.Gangakhedkar Head, Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research New Delhi Waves in Spread of HIV Epidemic Core Group Bridge Populationmostly

More information

AIDS 2010 XVIII International AIDS Conference Vienna July 2010

AIDS 2010 XVIII International AIDS Conference Vienna July 2010 Official provider of online scientific news AIDS 2010 AIDS 2010 XVIII International AIDS Conference Vienna 18-23 July 2010 Friday 23 July 2010 New drug rilpivirine does well in trials Rilpivirine (TMC278)

More information

SA HIV Clinicians Society Adult ART guidelines

SA HIV Clinicians Society Adult ART guidelines SA HIV Clinicians Society Adult ART guidelines In draft format Graeme Meintjes (on behalf of the guidelines committee) Selected topics When to start ART First-line Second-line Third-line Patients with

More information

TB and HIV co-infection including IRIS

TB and HIV co-infection including IRIS TB and HIV co-infection including IRIS Richard Lessells SAHCS Conference 2018 Clinical scenario 1 36-year-old male Presents with cough, fever & weight loss HIV test positive (new diagnosis) Sputum Xpert

More information

Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access -

Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access - Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access - Associate Professor, Bui Duc Duong, MD, Ph.D. Deputy Director General, Ministry of Health Socialist Republic of Viet Nam HIV

More information

Treat All : From Policy to Action - What will it take?

Treat All : From Policy to Action - What will it take? Strategy Finance Integration Cascade of services People centred Political Will Treat All : From Policy to Action - What will it take? Thursday, 9 June, 13.00 14.30 Conference Room 11, United Nations Questions

More information

Effective HIV & AIDS prevention strategies

Effective HIV & AIDS prevention strategies Effective HIV & AIDS prevention strategies Prof Geoffrey Setswe Presentation at the PDM2008 Satellite Broadcast 5 July 2008 1 Structure of the presentation Evidence and types of evidence in HIV prevention

More information

Arizona State Office of Rural Health Webinar Series

Arizona State Office of Rural Health Webinar Series Arizona State Office of Rural Health Webinar Series Mute your phone &/or computer microphone Time is reserved at the end for Q&A Please fill out the post-webinar survey Webinar is being recorded Recording

More information

HIV Drug Resistance (HIVDR)

HIV Drug Resistance (HIVDR) Technical Guidance Note for Round 10 Global Fund HIV Proposals HIV Drug Resistance (HIVDR) Rationale for including HIVDR prevention and assessment in the proposal June 2010 As access to ART services expands,

More information

Elements of Reproductive Health

Elements of Reproductive Health SEXUAL& REPRODUCTIVE HEALTH and HIV/AIDS INTEGRATION: Issues for consideration Dr. Chris Baryomunsi, MP Parliament of Uganda Elements of Reproductive Health Safe motherhood Family Planning Prevention and

More information

PRECONCEPTION COUNSELING

PRECONCEPTION COUNSELING PRECONCEPTION COUNSELING A Counseling Guide for Healthcare Providers Preconception Care & Counseling 1 Introduction Pregnancy planning and preconception care are important in order to: 1. Ensure maternal

More information

Update on Biomedical Prevention. Thomas C. Quinn, MD, MSc

Update on Biomedical Prevention. Thomas C. Quinn, MD, MSc Update on Biomedical Prevention Thomas C. Quinn, MD, MSc Associate Director of International Research National Institute of Allergy and Infectious Diseases Director, Johns Hopkins Center for Global Health

More information

Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS

Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS Republic of Botswana Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS Page 1 June 2012 1.0 Background HIV and AIDS remains one of the critical human development challenges in Botswana.

More information

BOTSWANA INTERNATIONAL HIV CONFERENCE: PREVENTION IS THE WAY FORWARD

BOTSWANA INTERNATIONAL HIV CONFERENCE: PREVENTION IS THE WAY FORWARD Tlaleletso HIV UPDATE: BOTSWANA HIV CONFERENCE Tlaleletso is a monthly publication produced by the Botswana UPenn Partnership, in response to your expressed need to have accessible, digestible clinical

More information

Translating Science to end HIV in Latin America and the Caribbean

Translating Science to end HIV in Latin America and the Caribbean Translating Science to end HIV in Latin America and the Caribbean Mexico City, Mexico, 17 th - 18 th and 21 st April www.iasociety.org IAS 2017 post-conference workshop, 17 April 2018 Challenges for PrEP

More information

Starting with the end in mind: Experience of transitioning to sustainable services (KZN)

Starting with the end in mind: Experience of transitioning to sustainable services (KZN) Starting with the end in mind: Experience of transitioning to sustainable services (KZN) Hilton Humphries Adolescent Programme Director MA (Research Psychology), PhD candidate Position: Behavioural Scientist

More information

Is dolutegravir a magic bullet for HIV/TB programmes?

Is dolutegravir a magic bullet for HIV/TB programmes? Francois Venter Is dolutegravir a magic bullet for HIV/TB programmes? March 2018 Thanks Michelle Moorhouse, Graeme Meintjes, Gary Maartens, Celicia Serenata, Andy Hill, Polly Clayden, Gloria Maimela, Tom

More information

LOGFRAME TEMPLATE FOR SWAZILAND. SIDA s Contributions

LOGFRAME TEMPLATE FOR SWAZILAND. SIDA s Contributions 1 Outcome 7 countries have addressed barriers to efficient and effective linkages between HIV and SRHR policies and services as part of strengthening health systems to increase access to and use of a broad

More information

S.A. HEALTH CALENDAR 2016

S.A. HEALTH CALENDAR 2016 S.A. HEALTH CALENDAR 2016 http://www.kznhealth.gov.za/health_awareness_days_2016.pdf We have a health poster set available 35 Laminated posters A3, full colour with a one pager of information. Contact

More information

TB/HIV Monitoring & Advocacy Project Interview Tool

TB/HIV Monitoring & Advocacy Project Interview Tool TB/HIV Monitoring & Advocacy Project Interview Tool This interview tool is based upon the Interim Policy on Collaborative TB/HIV Activities of the World Health Organization. 1 It is designed to help you

More information

INTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION

INTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION INTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES WHO guidelines [EXECUTIVE SUMMARY] NDoH PrEP policy [FULL] NDoH PrEP guidelines [FULL] FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION

More information

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

Sex Work in Sub-Saharan Africa : Opportunities and Challenges Sex Work in Sub-Saharan Africa : Opportunities and Challenges Dr Traore Isidore May 26, 2016 Definition of Sex Worker Female, male and transgender adults (18 years of age and above) who receive money or

More information

World Food Programme (WFP)

World Food Programme (WFP) UNAIDS 2016 REPORT World Food Programme (WFP) Unified Budget Results and Accountability Framework (UBRAF) 2016-2021 2 Contents Achievements 2 Introduction 2 Innovative testing strategies 2 Access to treatment

More information

HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016

HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016 HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016 1 Thus the HIV DR needs to focus on prevention and then diagnostic capacity to 1 st provide VL monitoring for early &

More information

Session 1 Basic HIV Facts. Patient Navigation Intervention

Session 1 Basic HIV Facts. Patient Navigation Intervention Session 1 Basic HIV Facts Patient Navigation Intervention Session 1 HIV, the Viral Life Cycle & Understanding the Importance of HAART and Adherence https://www.aids.gov/hiv aids basics/just diagnosed with

More information